Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2015

01.03.2015 | Innovation and Improvement: Innovations in Medical Education

An Inpatient Treatment and Discharge Planning Protocol for Alcohol Dependence: Efficacy in Reducing 30-Day Readmissions and Emergency Department Visits

verfasst von: Jennie Wei, MD, MPH, Triveni Defries, MD, MPH, Mia Lozada, MD, Natalie Young, MD, William Huen, MD, MS, MPH, Jacqueline Tulsky, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

ABSTRACT

BACKGROUND

Alcohol dependence results in multiple hospital readmissions, but no discharge planning protocol has been studied to improve outcomes. The inpatient setting is a frequently missed opportunity to discuss treatment of alcohol dependence and initiate medication-assisted treatment, which is effective yet rarely utilized.

AIM

Our aim was to implement and evaluate a discharge planning protocol for patients admitted with alcohol dependence.

SETTING

The study took place at the San Francisco General Hospital (SFGH), a university-affiliated, large urban county hospital.

PARTICIPANTS

Learner participants included Internal Medicine residents at the University of California, San Francisco (UCSF) who staff the teaching service at SFGH. Patient participants included inpatients with alcohol dependence admitted to the Internal Medicine teaching service.

PROGRAM DESCRIPTION

We developed and implemented a discharge planning protocol for patients admitted with alcohol dependence that included eligibility assessment and initiation of medication-assisted treatment.

PROGRAM EVALUATION

Rates of medication-assisted treatment increased from 0 % to 64 % (p value < 0.001). All-cause 30-day readmission rates to SFGH decreased from 23.4 % to 8.2 % (p value = 0.042). All-cause emergency department visits to SFGH within 30 days of discharge decreased from 18.8 % to 6.1 % (p value = 0.056).

DISCUSSION

Through implementation of a discharge planning protocol by Internal Medicine residents for patients admitted with alcohol dependence, there was a statistically significant increase in medication-assisted treatment and a statistically significant decrease in both 30-day readmission rates and emergency department visits.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2012. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2012.
2.
Zurück zum Zitat Amarasingham R, Patel PC, Toto K, et al. Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study. BMJ Qual Saf. 2013;22(12):998–1005.CrossRefPubMedCentralPubMed Amarasingham R, Patel PC, Toto K, et al. Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study. BMJ Qual Saf. 2013;22(12):998–1005.CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Ryan J, Kang S, Dolacky S, Ingrassia J, Ganeshan R. Change in readmissions and follow-up visits as part of a heart failure readmission quality improvement initiative. Am J Med. 2013;126(11):989–994.CrossRefPubMed Ryan J, Kang S, Dolacky S, Ingrassia J, Ganeshan R. Change in readmissions and follow-up visits as part of a heart failure readmission quality improvement initiative. Am J Med. 2013;126(11):989–994.CrossRefPubMed
4.
Zurück zum Zitat Lainscak M, Kadivec S, Kosnik M, et al. Discharge coordinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial. J Am Med Dir Assoc. 2013;14(6):450e1–6.CrossRef Lainscak M, Kadivec S, Kosnik M, et al. Discharge coordinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial. J Am Med Dir Assoc. 2013;14(6):450e1–6.CrossRef
6.
Zurück zum Zitat Chen JY, Ma Q, Chen H, Yermilov I. New bundled world: quality of care and readmission in diabetes patients. J Diabetes Sci Technol. 2012;6(3):563–71.CrossRefPubMedCentralPubMed Chen JY, Ma Q, Chen H, Yermilov I. New bundled world: quality of care and readmission in diabetes patients. J Diabetes Sci Technol. 2012;6(3):563–71.CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Healy SJ, Black D, Harris C, Lorenz A, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013;36(10):2960–7.CrossRefPubMedCentralPubMed Healy SJ, Black D, Harris C, Lorenz A, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013;36(10):2960–7.CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Stewart S, Swain S. Assessment and management of alcohol dependence and withdrawal in the acute hospital. Clin Med. 2012;12(3):266–71.CrossRefPubMed Stewart S, Swain S. Assessment and management of alcohol dependence and withdrawal in the acute hospital. Clin Med. 2012;12(3):266–71.CrossRefPubMed
9.
Zurück zum Zitat Weiss RD, Kueppenbender KD. Combining psychosocial treatment with pharmacotherapy for alcohol dependence. J Clin Psychopharmacol. 2006;26(Suppl 1):S37–S42.CrossRefPubMed Weiss RD, Kueppenbender KD. Combining psychosocial treatment with pharmacotherapy for alcohol dependence. J Clin Psychopharmacol. 2006;26(Suppl 1):S37–S42.CrossRefPubMed
10.
Zurück zum Zitat Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence. JAMA. 1999;281:1318–25.CrossRefPubMed Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence. JAMA. 1999;281:1318–25.CrossRefPubMed
11.
Zurück zum Zitat O'Malley SS, Kosten TR. Pharmacotherapy of addictive disorders. In: Miller WR, Carroll KM, eds. Rethinking substance abuse: what the science shows, and what we should do about it. New York: The Guilford Press; 2006:240–56. O'Malley SS, Kosten TR. Pharmacotherapy of addictive disorders. In: Miller WR, Carroll KM, eds. Rethinking substance abuse: what the science shows, and what we should do about it. New York: The Guilford Press; 2006:240–56.
12.
Zurück zum Zitat Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res. 2001;25:1335–41.CrossRefPubMed Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res. 2001;25:1335–41.CrossRefPubMed
13.
Zurück zum Zitat Srisurapanont M, Jarusuraisin N. Opioid antagonists for alcohol dependence (Review). Cochrane Database Syst Rev. 2005;2(1), CD001867. Srisurapanont M, Jarusuraisin N. Opioid antagonists for alcohol dependence (Review). Cochrane Database Syst Rev. 2005;2(1), CD001867.
14.
Zurück zum Zitat Streeton C, Whelan G. Naltrexone: a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol. 2001;36:544–52. Streeton C, Whelan G. Naltrexone: a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol. 2001;36:544–52.
15.
Zurück zum Zitat Pettinati HM, O’Brien CP, Rabinowitz AR, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol. 2006;26(6):610–25.CrossRefPubMed Pettinati HM, O’Brien CP, Rabinowitz AR, et al. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol. 2006;26(6):610–25.CrossRefPubMed
16.
Zurück zum Zitat Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003–17.CrossRefPubMed Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003–17.CrossRefPubMed
17.
Zurück zum Zitat Jones DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889–900.CrossRef Jones DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889–900.CrossRef
18.
Zurück zum Zitat Mason BJ. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review. J Clin Psychiatry. 2001;62(Suppl 10):42–8.PubMed Mason BJ. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review. J Clin Psychiatry. 2001;62(Suppl 10):42–8.PubMed
19.
Zurück zum Zitat Soyka M, Chick J. Use of acamprosate and opioid agonists in the treatment of alcohol dependence: a European perspective. Am J Addict. 2003;12(Suppl 1):S69–S80.CrossRefPubMed Soyka M, Chick J. Use of acamprosate and opioid agonists in the treatment of alcohol dependence: a European perspective. Am J Addict. 2003;12(Suppl 1):S69–S80.CrossRefPubMed
20.
Zurück zum Zitat Yahn SL, Watterson LR, Olive MF. Safety and efficacy of acamprosate for the treatment of alcohol dependence. Subst Abus. 2013;6:1–12. Yahn SL, Watterson LR, Olive MF. Safety and efficacy of acamprosate for the treatment of alcohol dependence. Subst Abus. 2013;6:1–12.
21.
Zurück zum Zitat Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. 2010;9:1–118. Rösner S, Hackl-Herrwerth A, Leucht S, Lehert P, Vecchi S, Soyka M. Acamprosate for alcohol dependence. Cochrane Database Syst Rev. 2010;9:1–118.
22.
Zurück zum Zitat Suh JJ, Pettinati HM, Kampman KM, O’Brien CP. The status of disulfiram: a half of a century later. J Clin Psychopharmacol. 2006;26(3):290–302.CrossRefPubMed Suh JJ, Pettinati HM, Kampman KM, O’Brien CP. The status of disulfiram: a half of a century later. J Clin Psychopharmacol. 2006;26(3):290–302.CrossRefPubMed
23.
Zurück zum Zitat Jorgensen CH, Pederson B, Tonnesen H. The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin Exp Res. 2011;35(10):1749–58.CrossRefPubMed Jorgensen CH, Pederson B, Tonnesen H. The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin Exp Res. 2011;35(10):1749–58.CrossRefPubMed
24.
Zurück zum Zitat US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. Incorporating Alcohol Pharmacotherapies Into Medical Practice, Treatment Improvement Protocol (TIP) Series, No. 49. Rockville, MD: Center for Substance Abuse Treatment; 2009. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. Incorporating Alcohol Pharmacotherapies Into Medical Practice, Treatment Improvement Protocol (TIP) Series, No. 49. Rockville, MD: Center for Substance Abuse Treatment; 2009.
27.
Zurück zum Zitat Petrakis IL, Leslie D, Rosenheck R. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs. Alcohol Clin Exp Res. 2003;27:1780–4.CrossRefPubMed Petrakis IL, Leslie D, Rosenheck R. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs. Alcohol Clin Exp Res. 2003;27:1780–4.CrossRefPubMed
28.
Zurück zum Zitat Mark TL, Kranzle HR, Song X. Understanding U.S. addiction physicians’ low rate of naltrexone prescription. Drug Alcohol Depend. 2003;71(3):219–228.CrossRefPubMed Mark TL, Kranzle HR, Song X. Understanding U.S. addiction physicians’ low rate of naltrexone prescription. Drug Alcohol Depend. 2003;71(3):219–228.CrossRefPubMed
29.
Zurück zum Zitat Stewart SH, Connors GJ. Interest in pharmacotherapy and primary care alcoholism treatment among medically hospitalized, alcohol dependent patients. J Addict Dis. 2007;26(2):63–69.CrossRefPubMed Stewart SH, Connors GJ. Interest in pharmacotherapy and primary care alcoholism treatment among medically hospitalized, alcohol dependent patients. J Addict Dis. 2007;26(2):63–69.CrossRefPubMed
30.
Zurück zum Zitat Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7–30.CrossRefPubMed Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7–30.CrossRefPubMed
31.
Zurück zum Zitat Davoudi M, Rawson RA, Davoudi M, Rawson RA. Screening, brief intervention, and referral to treatment (SBIRT) initiatives in California: notable trends, challenges, and recommendations. J Psychoactive Drugs. 2010;Suppl 6:239–48.CrossRefPubMed Davoudi M, Rawson RA, Davoudi M, Rawson RA. Screening, brief intervention, and referral to treatment (SBIRT) initiatives in California: notable trends, challenges, and recommendations. J Psychoactive Drugs. 2010;Suppl 6:239–48.CrossRefPubMed
32.
Zurück zum Zitat Hettema JE, Ratanawongsa N, Manuel JK, et al. A SBIRT curriculum for medical residents: development of a performance feedback tool to build learner confidence. Subst Abus. 2012;33(3):241–50.CrossRefPubMedCentralPubMed Hettema JE, Ratanawongsa N, Manuel JK, et al. A SBIRT curriculum for medical residents: development of a performance feedback tool to build learner confidence. Subst Abus. 2012;33(3):241–50.CrossRefPubMedCentralPubMed
Metadaten
Titel
An Inpatient Treatment and Discharge Planning Protocol for Alcohol Dependence: Efficacy in Reducing 30-Day Readmissions and Emergency Department Visits
verfasst von
Jennie Wei, MD, MPH
Triveni Defries, MD, MPH
Mia Lozada, MD
Natalie Young, MD
William Huen, MD, MS, MPH
Jacqueline Tulsky, MD
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2015
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-014-2968-9

Weitere Artikel der Ausgabe 3/2015

Journal of General Internal Medicine 3/2015 Zur Ausgabe

Healing Arts

“Heart”

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.